CoryLGambleDOFACOI, FACE
Endocrinology • Fort Smith, ARDiabetes, Lipid Metabolism
US Medical Lead Victoza
Dr. Gamble is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6801 Rogers Ave
Fort Smith, AR 72903Phone+1 479-452-2077
Education & Training
University of Oklahoma Health Sciences CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1985 - 1987
Oklahoma State University Center for Health SciencesClass of 1982
Certifications & Licensure
OK State License 1984 - 2023
AR State License 1983 - 2021
Publications & Presentations
PubMed
- 12 citationsCost-effectiveness and budget impact of liraglutide in type 2 diabetes patients with elevated cardiovascular risk: a US-managed care perspectiveDhvani Shah, Nancy Risebrough, Johnna Perdrizet, Neeraj N. Iyer, Cory Gamble
Clinicoeconomics and Outcomes Research. 2018-11-14 - 2 citationsReal-world Effectiveness of Liraglutide vs. Sitagliptin Among Older Patients with Type 2 Diabetes Enrolled in a Medicare Advantage Prescription Drug Plan: A Retrospect...Tam Dang-Tan, Pravin Kamble, Yunus Meah, Cory Gamble, Rahul Ganguly
Diabetes Therapy. 2020-01-01 - 6 citationsReal-World Clinical Effectiveness and Cost Savings of Liraglutide Versus Sitagliptin in Treating Type 2 Diabetes for 1 and 2 YearsQian Li, Rahul Ganguly, Michael L. Ganz, Cory Gamble, Tam Dang-Tan
Diabetes Therapy. 2018-05-09
Professional Memberships
- Member
Industry Relationships
- US Medical Director Victoza, Novo Nordisk Inc2008 - 2014
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
